ACT-Accelerator Celebrates 1st Anniversary Amid COVID-19 Surge in India 23/04/2021 Kerry Cullinan One of the few silver linings of the COVID-19 pandemic is the unprecedented collaboration of every sector of society to overcome it – best demonstrated by the Access to COVID-19 Tools Accelerator (ACT-Accelerator), which celebrated its first anniversary on Friday. The ACT-Accelerator’s most famous pillar is the vaccine facility, COVAX, which has distributed almost 40 […] Continue reading -> WHO Launches Initiative To End Malaria in 25 Countries On The Cusp Of Disease Elimination 22/04/2021 Madeleine Hoecklin Progress towards global malaria targets has stalled in recent years, and the COVID-19 pandemic has posed a serious threat to malaria responses worldwide, but a number of countries are nearing the goal of zero cases of malaria, said WHO, in a forum convened just ahead of World Malaria Day on 25 April. The forum Reaching Zero: […] Continue reading -> Increased Funding For Leading Infectious Diseases; Neglected Disease Funding Stagnant 16/04/2021 Raisa Santos Global funding to develop new drugs for some of the world’s leading infectious disease killers, such as HIV/AIDS, TB, and malaria, was US $3.876 billion, with the drop of US $185 million from 2018 reflecting COVID-related difficulties in data collection, according to the G-Finder Report, which tracks annual global investments. However, once participation is accounted […] Continue reading -> Papua New Guinea’s COVID-19 Surge Coincides With ‘Worrying’ Global Increases, Say WHO Officials 16/04/2021 Madeleine Hoecklin As the world quickly approaches the highest weekly rate of infection recorded since the start of the pandemic over a year ago, several countries that have largely held COVID-19 at bay so far are seeing surges in infections. Papua New Guinea (PNG), a small Pacific island state that successfully shielded itself from the SARS-CoV2 virus […] Continue reading -> Africa Plots Ambitious Vaccine Targets at Manufacturing Conference 12/04/2021 Paul Adepoju African vaccine producers supply just 1% of the continent’s needs at present – but the plan is to increase this to 60% by 2040, according to John Nkengasong, Director of the Africa Centers for Disease Control (CDC). “The vision is to ensure Africa has timely access to vaccines to protect public health security, by establishing […] Continue reading -> WHO Calls For Global ‘Reality Check’ As Cases Surge And Countries Abandon Basics 12/04/2021 Kerry Cullinan The World Health Organization (WHO) has called for a global “reality check” as COVID-19 infections increased by 4.4 million in the past week, with countries and individuals abandoning proven methods to protect themselves. “This is not the situation we want to be in 16 months into a pandemic, where we have proven control measures. It […] Continue reading -> European Medicines Agency: Link Between AstraZeneca COVID Vaccine & Rare Blood Clots – But ‘Benefits Far Outweigh Risks’ 07/04/2021 Elaine Ruth Fletcher Following a second meeting of the EMA’s safety committee in as many weeks, the European Medicines Agency said that there appears to be a link between receipt of the AstraZeneca vaccine and very rare cases of blood clots being seen in some people – mainly younger women – within two weeks of their jab. The […] Continue reading -> Damage To Millions Of J&J COVID Vaccines At US Production Plant Could Delay Deliveries, While US Heads Into Fourth Wave 02/04/2021 Madeleine Hoecklin A mix-up with vaccine ingredients at a production site in Baltimore, Maryland, which is manufacturing both the Johnson & Johnson and AstraZeneca COVID-19 vaccines, has led to the contamination of 15 million J&J doses, which risks delaying national and global deliveries of the recently-approved vaccine. The pharma company, which is producing the world’s first single […] Continue reading -> Ivermectin For COVID: Insignificant Results In Treatment Of Mild Cases – WHO Recommends Use Only In Clinical Trials 02/04/2021 Editorial team A recent trial of ivermectin, a mainstay treatment for the parasitic disease onchocerciasis for the past three decades, has failed to show significant impacts against COVID-19, a new study, published in JAMA, reports. The study by a group of researchers in Cali, Colombia found that the use of the antiparitic drug, typically used to treat onchocersiasis […] Continue reading -> France Enters Third Lockdown, While Europe’s Vaccine Rollout Is Critiqued As “Unacceptably Slow” 01/04/2021 Madeleine Hoecklin France is going into its third national lockdown since the start of the COVID-19 pandemic, after a deadly third wave hit Europe, causing soaring infection and death rates. With an average of more than 37,000 daily new cases over the past week, tougher restrictions have become inevitable. French President Emmanuel Macron announced the new restrictions […] Continue reading -> Posts navigation Older postsNewer posts
WHO Launches Initiative To End Malaria in 25 Countries On The Cusp Of Disease Elimination 22/04/2021 Madeleine Hoecklin Progress towards global malaria targets has stalled in recent years, and the COVID-19 pandemic has posed a serious threat to malaria responses worldwide, but a number of countries are nearing the goal of zero cases of malaria, said WHO, in a forum convened just ahead of World Malaria Day on 25 April. The forum Reaching Zero: […] Continue reading -> Increased Funding For Leading Infectious Diseases; Neglected Disease Funding Stagnant 16/04/2021 Raisa Santos Global funding to develop new drugs for some of the world’s leading infectious disease killers, such as HIV/AIDS, TB, and malaria, was US $3.876 billion, with the drop of US $185 million from 2018 reflecting COVID-related difficulties in data collection, according to the G-Finder Report, which tracks annual global investments. However, once participation is accounted […] Continue reading -> Papua New Guinea’s COVID-19 Surge Coincides With ‘Worrying’ Global Increases, Say WHO Officials 16/04/2021 Madeleine Hoecklin As the world quickly approaches the highest weekly rate of infection recorded since the start of the pandemic over a year ago, several countries that have largely held COVID-19 at bay so far are seeing surges in infections. Papua New Guinea (PNG), a small Pacific island state that successfully shielded itself from the SARS-CoV2 virus […] Continue reading -> Africa Plots Ambitious Vaccine Targets at Manufacturing Conference 12/04/2021 Paul Adepoju African vaccine producers supply just 1% of the continent’s needs at present – but the plan is to increase this to 60% by 2040, according to John Nkengasong, Director of the Africa Centers for Disease Control (CDC). “The vision is to ensure Africa has timely access to vaccines to protect public health security, by establishing […] Continue reading -> WHO Calls For Global ‘Reality Check’ As Cases Surge And Countries Abandon Basics 12/04/2021 Kerry Cullinan The World Health Organization (WHO) has called for a global “reality check” as COVID-19 infections increased by 4.4 million in the past week, with countries and individuals abandoning proven methods to protect themselves. “This is not the situation we want to be in 16 months into a pandemic, where we have proven control measures. It […] Continue reading -> European Medicines Agency: Link Between AstraZeneca COVID Vaccine & Rare Blood Clots – But ‘Benefits Far Outweigh Risks’ 07/04/2021 Elaine Ruth Fletcher Following a second meeting of the EMA’s safety committee in as many weeks, the European Medicines Agency said that there appears to be a link between receipt of the AstraZeneca vaccine and very rare cases of blood clots being seen in some people – mainly younger women – within two weeks of their jab. The […] Continue reading -> Damage To Millions Of J&J COVID Vaccines At US Production Plant Could Delay Deliveries, While US Heads Into Fourth Wave 02/04/2021 Madeleine Hoecklin A mix-up with vaccine ingredients at a production site in Baltimore, Maryland, which is manufacturing both the Johnson & Johnson and AstraZeneca COVID-19 vaccines, has led to the contamination of 15 million J&J doses, which risks delaying national and global deliveries of the recently-approved vaccine. The pharma company, which is producing the world’s first single […] Continue reading -> Ivermectin For COVID: Insignificant Results In Treatment Of Mild Cases – WHO Recommends Use Only In Clinical Trials 02/04/2021 Editorial team A recent trial of ivermectin, a mainstay treatment for the parasitic disease onchocerciasis for the past three decades, has failed to show significant impacts against COVID-19, a new study, published in JAMA, reports. The study by a group of researchers in Cali, Colombia found that the use of the antiparitic drug, typically used to treat onchocersiasis […] Continue reading -> France Enters Third Lockdown, While Europe’s Vaccine Rollout Is Critiqued As “Unacceptably Slow” 01/04/2021 Madeleine Hoecklin France is going into its third national lockdown since the start of the COVID-19 pandemic, after a deadly third wave hit Europe, causing soaring infection and death rates. With an average of more than 37,000 daily new cases over the past week, tougher restrictions have become inevitable. French President Emmanuel Macron announced the new restrictions […] Continue reading -> Posts navigation Older postsNewer posts
Increased Funding For Leading Infectious Diseases; Neglected Disease Funding Stagnant 16/04/2021 Raisa Santos Global funding to develop new drugs for some of the world’s leading infectious disease killers, such as HIV/AIDS, TB, and malaria, was US $3.876 billion, with the drop of US $185 million from 2018 reflecting COVID-related difficulties in data collection, according to the G-Finder Report, which tracks annual global investments. However, once participation is accounted […] Continue reading -> Papua New Guinea’s COVID-19 Surge Coincides With ‘Worrying’ Global Increases, Say WHO Officials 16/04/2021 Madeleine Hoecklin As the world quickly approaches the highest weekly rate of infection recorded since the start of the pandemic over a year ago, several countries that have largely held COVID-19 at bay so far are seeing surges in infections. Papua New Guinea (PNG), a small Pacific island state that successfully shielded itself from the SARS-CoV2 virus […] Continue reading -> Africa Plots Ambitious Vaccine Targets at Manufacturing Conference 12/04/2021 Paul Adepoju African vaccine producers supply just 1% of the continent’s needs at present – but the plan is to increase this to 60% by 2040, according to John Nkengasong, Director of the Africa Centers for Disease Control (CDC). “The vision is to ensure Africa has timely access to vaccines to protect public health security, by establishing […] Continue reading -> WHO Calls For Global ‘Reality Check’ As Cases Surge And Countries Abandon Basics 12/04/2021 Kerry Cullinan The World Health Organization (WHO) has called for a global “reality check” as COVID-19 infections increased by 4.4 million in the past week, with countries and individuals abandoning proven methods to protect themselves. “This is not the situation we want to be in 16 months into a pandemic, where we have proven control measures. It […] Continue reading -> European Medicines Agency: Link Between AstraZeneca COVID Vaccine & Rare Blood Clots – But ‘Benefits Far Outweigh Risks’ 07/04/2021 Elaine Ruth Fletcher Following a second meeting of the EMA’s safety committee in as many weeks, the European Medicines Agency said that there appears to be a link between receipt of the AstraZeneca vaccine and very rare cases of blood clots being seen in some people – mainly younger women – within two weeks of their jab. The […] Continue reading -> Damage To Millions Of J&J COVID Vaccines At US Production Plant Could Delay Deliveries, While US Heads Into Fourth Wave 02/04/2021 Madeleine Hoecklin A mix-up with vaccine ingredients at a production site in Baltimore, Maryland, which is manufacturing both the Johnson & Johnson and AstraZeneca COVID-19 vaccines, has led to the contamination of 15 million J&J doses, which risks delaying national and global deliveries of the recently-approved vaccine. The pharma company, which is producing the world’s first single […] Continue reading -> Ivermectin For COVID: Insignificant Results In Treatment Of Mild Cases – WHO Recommends Use Only In Clinical Trials 02/04/2021 Editorial team A recent trial of ivermectin, a mainstay treatment for the parasitic disease onchocerciasis for the past three decades, has failed to show significant impacts against COVID-19, a new study, published in JAMA, reports. The study by a group of researchers in Cali, Colombia found that the use of the antiparitic drug, typically used to treat onchocersiasis […] Continue reading -> France Enters Third Lockdown, While Europe’s Vaccine Rollout Is Critiqued As “Unacceptably Slow” 01/04/2021 Madeleine Hoecklin France is going into its third national lockdown since the start of the COVID-19 pandemic, after a deadly third wave hit Europe, causing soaring infection and death rates. With an average of more than 37,000 daily new cases over the past week, tougher restrictions have become inevitable. French President Emmanuel Macron announced the new restrictions […] Continue reading -> Posts navigation Older postsNewer posts
Papua New Guinea’s COVID-19 Surge Coincides With ‘Worrying’ Global Increases, Say WHO Officials 16/04/2021 Madeleine Hoecklin As the world quickly approaches the highest weekly rate of infection recorded since the start of the pandemic over a year ago, several countries that have largely held COVID-19 at bay so far are seeing surges in infections. Papua New Guinea (PNG), a small Pacific island state that successfully shielded itself from the SARS-CoV2 virus […] Continue reading -> Africa Plots Ambitious Vaccine Targets at Manufacturing Conference 12/04/2021 Paul Adepoju African vaccine producers supply just 1% of the continent’s needs at present – but the plan is to increase this to 60% by 2040, according to John Nkengasong, Director of the Africa Centers for Disease Control (CDC). “The vision is to ensure Africa has timely access to vaccines to protect public health security, by establishing […] Continue reading -> WHO Calls For Global ‘Reality Check’ As Cases Surge And Countries Abandon Basics 12/04/2021 Kerry Cullinan The World Health Organization (WHO) has called for a global “reality check” as COVID-19 infections increased by 4.4 million in the past week, with countries and individuals abandoning proven methods to protect themselves. “This is not the situation we want to be in 16 months into a pandemic, where we have proven control measures. It […] Continue reading -> European Medicines Agency: Link Between AstraZeneca COVID Vaccine & Rare Blood Clots – But ‘Benefits Far Outweigh Risks’ 07/04/2021 Elaine Ruth Fletcher Following a second meeting of the EMA’s safety committee in as many weeks, the European Medicines Agency said that there appears to be a link between receipt of the AstraZeneca vaccine and very rare cases of blood clots being seen in some people – mainly younger women – within two weeks of their jab. The […] Continue reading -> Damage To Millions Of J&J COVID Vaccines At US Production Plant Could Delay Deliveries, While US Heads Into Fourth Wave 02/04/2021 Madeleine Hoecklin A mix-up with vaccine ingredients at a production site in Baltimore, Maryland, which is manufacturing both the Johnson & Johnson and AstraZeneca COVID-19 vaccines, has led to the contamination of 15 million J&J doses, which risks delaying national and global deliveries of the recently-approved vaccine. The pharma company, which is producing the world’s first single […] Continue reading -> Ivermectin For COVID: Insignificant Results In Treatment Of Mild Cases – WHO Recommends Use Only In Clinical Trials 02/04/2021 Editorial team A recent trial of ivermectin, a mainstay treatment for the parasitic disease onchocerciasis for the past three decades, has failed to show significant impacts against COVID-19, a new study, published in JAMA, reports. The study by a group of researchers in Cali, Colombia found that the use of the antiparitic drug, typically used to treat onchocersiasis […] Continue reading -> France Enters Third Lockdown, While Europe’s Vaccine Rollout Is Critiqued As “Unacceptably Slow” 01/04/2021 Madeleine Hoecklin France is going into its third national lockdown since the start of the COVID-19 pandemic, after a deadly third wave hit Europe, causing soaring infection and death rates. With an average of more than 37,000 daily new cases over the past week, tougher restrictions have become inevitable. French President Emmanuel Macron announced the new restrictions […] Continue reading -> Posts navigation Older postsNewer posts
Africa Plots Ambitious Vaccine Targets at Manufacturing Conference 12/04/2021 Paul Adepoju African vaccine producers supply just 1% of the continent’s needs at present – but the plan is to increase this to 60% by 2040, according to John Nkengasong, Director of the Africa Centers for Disease Control (CDC). “The vision is to ensure Africa has timely access to vaccines to protect public health security, by establishing […] Continue reading -> WHO Calls For Global ‘Reality Check’ As Cases Surge And Countries Abandon Basics 12/04/2021 Kerry Cullinan The World Health Organization (WHO) has called for a global “reality check” as COVID-19 infections increased by 4.4 million in the past week, with countries and individuals abandoning proven methods to protect themselves. “This is not the situation we want to be in 16 months into a pandemic, where we have proven control measures. It […] Continue reading -> European Medicines Agency: Link Between AstraZeneca COVID Vaccine & Rare Blood Clots – But ‘Benefits Far Outweigh Risks’ 07/04/2021 Elaine Ruth Fletcher Following a second meeting of the EMA’s safety committee in as many weeks, the European Medicines Agency said that there appears to be a link between receipt of the AstraZeneca vaccine and very rare cases of blood clots being seen in some people – mainly younger women – within two weeks of their jab. The […] Continue reading -> Damage To Millions Of J&J COVID Vaccines At US Production Plant Could Delay Deliveries, While US Heads Into Fourth Wave 02/04/2021 Madeleine Hoecklin A mix-up with vaccine ingredients at a production site in Baltimore, Maryland, which is manufacturing both the Johnson & Johnson and AstraZeneca COVID-19 vaccines, has led to the contamination of 15 million J&J doses, which risks delaying national and global deliveries of the recently-approved vaccine. The pharma company, which is producing the world’s first single […] Continue reading -> Ivermectin For COVID: Insignificant Results In Treatment Of Mild Cases – WHO Recommends Use Only In Clinical Trials 02/04/2021 Editorial team A recent trial of ivermectin, a mainstay treatment for the parasitic disease onchocerciasis for the past three decades, has failed to show significant impacts against COVID-19, a new study, published in JAMA, reports. The study by a group of researchers in Cali, Colombia found that the use of the antiparitic drug, typically used to treat onchocersiasis […] Continue reading -> France Enters Third Lockdown, While Europe’s Vaccine Rollout Is Critiqued As “Unacceptably Slow” 01/04/2021 Madeleine Hoecklin France is going into its third national lockdown since the start of the COVID-19 pandemic, after a deadly third wave hit Europe, causing soaring infection and death rates. With an average of more than 37,000 daily new cases over the past week, tougher restrictions have become inevitable. French President Emmanuel Macron announced the new restrictions […] Continue reading -> Posts navigation Older postsNewer posts
WHO Calls For Global ‘Reality Check’ As Cases Surge And Countries Abandon Basics 12/04/2021 Kerry Cullinan The World Health Organization (WHO) has called for a global “reality check” as COVID-19 infections increased by 4.4 million in the past week, with countries and individuals abandoning proven methods to protect themselves. “This is not the situation we want to be in 16 months into a pandemic, where we have proven control measures. It […] Continue reading -> European Medicines Agency: Link Between AstraZeneca COVID Vaccine & Rare Blood Clots – But ‘Benefits Far Outweigh Risks’ 07/04/2021 Elaine Ruth Fletcher Following a second meeting of the EMA’s safety committee in as many weeks, the European Medicines Agency said that there appears to be a link between receipt of the AstraZeneca vaccine and very rare cases of blood clots being seen in some people – mainly younger women – within two weeks of their jab. The […] Continue reading -> Damage To Millions Of J&J COVID Vaccines At US Production Plant Could Delay Deliveries, While US Heads Into Fourth Wave 02/04/2021 Madeleine Hoecklin A mix-up with vaccine ingredients at a production site in Baltimore, Maryland, which is manufacturing both the Johnson & Johnson and AstraZeneca COVID-19 vaccines, has led to the contamination of 15 million J&J doses, which risks delaying national and global deliveries of the recently-approved vaccine. The pharma company, which is producing the world’s first single […] Continue reading -> Ivermectin For COVID: Insignificant Results In Treatment Of Mild Cases – WHO Recommends Use Only In Clinical Trials 02/04/2021 Editorial team A recent trial of ivermectin, a mainstay treatment for the parasitic disease onchocerciasis for the past three decades, has failed to show significant impacts against COVID-19, a new study, published in JAMA, reports. The study by a group of researchers in Cali, Colombia found that the use of the antiparitic drug, typically used to treat onchocersiasis […] Continue reading -> France Enters Third Lockdown, While Europe’s Vaccine Rollout Is Critiqued As “Unacceptably Slow” 01/04/2021 Madeleine Hoecklin France is going into its third national lockdown since the start of the COVID-19 pandemic, after a deadly third wave hit Europe, causing soaring infection and death rates. With an average of more than 37,000 daily new cases over the past week, tougher restrictions have become inevitable. French President Emmanuel Macron announced the new restrictions […] Continue reading -> Posts navigation Older postsNewer posts
European Medicines Agency: Link Between AstraZeneca COVID Vaccine & Rare Blood Clots – But ‘Benefits Far Outweigh Risks’ 07/04/2021 Elaine Ruth Fletcher Following a second meeting of the EMA’s safety committee in as many weeks, the European Medicines Agency said that there appears to be a link between receipt of the AstraZeneca vaccine and very rare cases of blood clots being seen in some people – mainly younger women – within two weeks of their jab. The […] Continue reading -> Damage To Millions Of J&J COVID Vaccines At US Production Plant Could Delay Deliveries, While US Heads Into Fourth Wave 02/04/2021 Madeleine Hoecklin A mix-up with vaccine ingredients at a production site in Baltimore, Maryland, which is manufacturing both the Johnson & Johnson and AstraZeneca COVID-19 vaccines, has led to the contamination of 15 million J&J doses, which risks delaying national and global deliveries of the recently-approved vaccine. The pharma company, which is producing the world’s first single […] Continue reading -> Ivermectin For COVID: Insignificant Results In Treatment Of Mild Cases – WHO Recommends Use Only In Clinical Trials 02/04/2021 Editorial team A recent trial of ivermectin, a mainstay treatment for the parasitic disease onchocerciasis for the past three decades, has failed to show significant impacts against COVID-19, a new study, published in JAMA, reports. The study by a group of researchers in Cali, Colombia found that the use of the antiparitic drug, typically used to treat onchocersiasis […] Continue reading -> France Enters Third Lockdown, While Europe’s Vaccine Rollout Is Critiqued As “Unacceptably Slow” 01/04/2021 Madeleine Hoecklin France is going into its third national lockdown since the start of the COVID-19 pandemic, after a deadly third wave hit Europe, causing soaring infection and death rates. With an average of more than 37,000 daily new cases over the past week, tougher restrictions have become inevitable. French President Emmanuel Macron announced the new restrictions […] Continue reading -> Posts navigation Older postsNewer posts
Damage To Millions Of J&J COVID Vaccines At US Production Plant Could Delay Deliveries, While US Heads Into Fourth Wave 02/04/2021 Madeleine Hoecklin A mix-up with vaccine ingredients at a production site in Baltimore, Maryland, which is manufacturing both the Johnson & Johnson and AstraZeneca COVID-19 vaccines, has led to the contamination of 15 million J&J doses, which risks delaying national and global deliveries of the recently-approved vaccine. The pharma company, which is producing the world’s first single […] Continue reading -> Ivermectin For COVID: Insignificant Results In Treatment Of Mild Cases – WHO Recommends Use Only In Clinical Trials 02/04/2021 Editorial team A recent trial of ivermectin, a mainstay treatment for the parasitic disease onchocerciasis for the past three decades, has failed to show significant impacts against COVID-19, a new study, published in JAMA, reports. The study by a group of researchers in Cali, Colombia found that the use of the antiparitic drug, typically used to treat onchocersiasis […] Continue reading -> France Enters Third Lockdown, While Europe’s Vaccine Rollout Is Critiqued As “Unacceptably Slow” 01/04/2021 Madeleine Hoecklin France is going into its third national lockdown since the start of the COVID-19 pandemic, after a deadly third wave hit Europe, causing soaring infection and death rates. With an average of more than 37,000 daily new cases over the past week, tougher restrictions have become inevitable. French President Emmanuel Macron announced the new restrictions […] Continue reading -> Posts navigation Older postsNewer posts
Ivermectin For COVID: Insignificant Results In Treatment Of Mild Cases – WHO Recommends Use Only In Clinical Trials 02/04/2021 Editorial team A recent trial of ivermectin, a mainstay treatment for the parasitic disease onchocerciasis for the past three decades, has failed to show significant impacts against COVID-19, a new study, published in JAMA, reports. The study by a group of researchers in Cali, Colombia found that the use of the antiparitic drug, typically used to treat onchocersiasis […] Continue reading -> France Enters Third Lockdown, While Europe’s Vaccine Rollout Is Critiqued As “Unacceptably Slow” 01/04/2021 Madeleine Hoecklin France is going into its third national lockdown since the start of the COVID-19 pandemic, after a deadly third wave hit Europe, causing soaring infection and death rates. With an average of more than 37,000 daily new cases over the past week, tougher restrictions have become inevitable. French President Emmanuel Macron announced the new restrictions […] Continue reading -> Posts navigation Older postsNewer posts
France Enters Third Lockdown, While Europe’s Vaccine Rollout Is Critiqued As “Unacceptably Slow” 01/04/2021 Madeleine Hoecklin France is going into its third national lockdown since the start of the COVID-19 pandemic, after a deadly third wave hit Europe, causing soaring infection and death rates. With an average of more than 37,000 daily new cases over the past week, tougher restrictions have become inevitable. French President Emmanuel Macron announced the new restrictions […] Continue reading -> Posts navigation Older postsNewer posts